From April 28, 2023 to June 30, 2023, the company has repurchased 421,100 shares, representing 0.25% for CNY 5.07 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.16 CNY | -6.53% | -6.14% | -23.40% |
1st Jan change | Capi. | |
---|---|---|
-23.40% | 261M | |
+13.74% | 8.18B | |
+5.29% | 7.53B | |
-0.42% | 5.89B | |
-6.67% | 3.7B | |
-10.75% | 3.57B | |
-8.21% | 1.26B | |
-29.10% | 1.08B | |
+14.92% | 991M | |
-12.46% | 894M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.